Click here to receive MS news via e-mail
JUNE 23, 2016
By: Carolina Henriques
An upcoming conference will explore new and emerging treatment options for multiple sclerosis (MS), focusing on the intersection between laboratory findings and clinical care, and the search for discoveries that may lead to important innovations in treating this neurological disease.
The daylong conference, open to academics, clinical researchers and industry leaders, is hosted by the New York Academy of Sciences (NYAS), and titled “Multiple Sclerosis: Diagnostic and Treatment Frontiers.” It will take place on June 28 at NYAS offices in Manhattan. Teva Pharmaceutical Industries Ltd. is a main event sponsor.
Plenary sessions will cover current therapies; MS diagnostics, prognostics and predictive biomarkers; the use of magnetic resonance imaging (MRI) scans to diagnose and monitor patients; and emerging treatment data. A session on “Late-breaking Data Blitz Presentations,” looking at myelin-reactive T-cells and axonal damage, is also planned. Details on each session are available through this NYAS link.
MS Views and News
Providing educational information, resources and services for those affected by MS
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews